Skip to main content
IVVD
NASDAQ Life Sciences

Invivyd Q2 Loss Widens to $44M, Misses Estimates on Higher Trial Costs

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.666
Mkt Cap
$202.012M
52W Low
$0.483
52W High
$3.07
52W Position info
38% above low
Off High info
78% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

IVVD sits 38% above its 52-week low of $0.483.

Summary

Invivyd reported a Q2 net loss of $44.39 million, or $0.14 per share, missing consensus estimates of $0.11 per share and $26.98 million net loss. Revenue rose 21% year-over-year to $14.29 million on higher PEMGARDA patient demand, but R&D and SG&A costs surged, driven by the DECLARATION and LIBERTY Phase 3 trials. The company ended the quarter with $160.1 million in cash, which it says funds operations through the DECLARATION pivotal data readout and potential VYD2311 launch readiness. Top-line data from both trials is expected in late Q3 2026. This follows the Nasdaq delisting notice received in July after the stock closed below $1.00 for 30 consecutive days, adding pressure on the company to deliver positive clinical results.

At the time of this announcement, IVVD was trading at $0.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $202M. The 52-week trading range was $0.48 to $3.07. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IVVD - Latest Insights

IVVD
Nov 16, 2026, 7:10 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.5867
Real-time Price: $0.5606 info
Change: -$0.0261 (-4%) info
Market Cap: $166.067M info
IVVD
Nov 16, 2026, 7:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.562
Real-time Price: $0.5606 info
Change: -$0.0014 (-0.25%) info
Market Cap: $166.067M info
IVVD
Nov 16, 2026, 7:02 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.5731
Real-time Price: $0.5606 info
Change: -$0.0125 (-2%) info
Market Cap: $166.067M info
IVVD
Sep 29, 2026, 7:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.9635
Real-time Price: $0.5606 info
Change: -$0.4029 (-42%) info
Market Cap: $166.067M info
IVVD
Sep 29, 2026, 7:07 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.16
Real-time Price: $0.5606 info
Change: -$0.5992 (-52%) info
Market Cap: $166.067M info